Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
Help || About || Contact

  
|  Previous Page  |
  |  Special Topics Menu  |  |  Next Page  |
  

ESI Special Topic of:
"Diabetes," Published March 2002

•> Search Special Topics
Diabetes Menu

Diabetes

 

FEATURES:


An interview with:
Professor Leif Groop, M.D., Ph.D.
September 2002
Professor Leif Groop of the Department of Endocrinology, Lund University, Sweden, discusses his work on clinical, metabolic, and molecular aspects of diabetes. In our analysis of diabetes research over the past decade, Professor Groop has 31 papers cited a total of 1,606 times.
[read] Click to read

An interview with:
Dr. Jaakko Tuomilehto
August 2002
Dr. Jaakko Tuomilehto about his highly cited work in diabetes research. Our analysis shows that Dr. Tuomilehto ranks at #12 among the 25 most-cited scientists performing research in this field, with 146 papers cited a total of 1,955 times. 
[read] Click to read

An essay by:
Professor Anthony Barnett
July 2002
Professor Anthony Barnett talks about his highly cited work in diabetes investigation. Professor Barnett is among the top 20 scientists cited in our Special Topics analysis of diabetes over the past decade, with 74 papers cited a total of 2,034 times. 
[read] Click to read
Dr. Walter Willett
An interview with:
Dr. Walter Willett
June 2002
Dr. Walter Willett ranks among the top 25 authors publishing in this field in the past decade, with 46 papers cited a total of 1,624 times. Dr. Willett’s work can be found in ISI Essential Science Indicators Web product in the field of Clinical Medicine. He is the Fredrick John Stare Professor of Epidemiology and Nutrition at the Harvard School of Public Health in Boston, Massachusetts.
[read] Click to read

Professor Anthony Barnett

Dr. George Eisenbarth
An interview with:
Dr. George Eisenbarth
May 2002
Dr. George Eisenbarth about his highly cited work on diabetes. Dr. Eisenbarth ranked among the top 20 scientists in terms of total citations in our analysis of diabetes research over the past decade, with 110 papers cited a total of 1,825 times.
[read] Click to read
Dr. John Todd
An essay by:
Dr. John Todd
April 2002
One of the most-cited scientists in diabetes research in the past decade, Dr. John Todd, relates the progress that has been made in elucidating the causes and prevention of type 1 diabetes in recent years. In our Special Topics analysis of diabetes research, Dr. Todd ranks at #2, with 76 papers meeting the search criteria cited a total of 4,002 times. Two of his papers also made the top 25 papers list in this analysis.
[read] Click to read
Dr. Mark Atkinson
An interview with:
Dr. Mark Atkinson
March 2002
Dr. Mark Atkinson talks about his highly cited career in diabetes research. The Special Topics analysis of diabetes research in the past decade places Dr. Atkinson among the top 5 scientists, with 48 papers cited a total of 2,724 times. His most-cited paper in this analysis is "Spontaneous loss of T-cell tolerance to glutamic-acid decarboxylase in murine insulin-dependent diabetes," (Nature 366 [6450]: 69-72; 4 November 1993), which has been cited 652 times to date.
[read] Click to read

ESI Special Topic of:
"Diabetes," Published March 2002

•> Search Special Topics
Diabetes Menu || All Topics Menu

Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.